A new horizon of precision medicine: combination of the microbiome and extracellular vesicles
Open Access
- 22 April 2022
- journal article
- review article
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 54 (4) , 466-482
Abstract
Over several decades, the disease pattern of intractable disease has changed from acute infection to chronic disease accompanied by immune and metabolic dysfunction. In addition, scientific evidence has shown that humans are holobionts; of the DNA in humans, 1% is derived from the human genome, and 99% is derived from microbial genomes (the microbiome). Extracellular vesicles (EVs) are lipid bilayer-delimited nanoparticles and key messengers in cell-to-cell communication. Many publications indicate that microbial EVs are both positively and negatively involved in the pathogenesis of various intractable diseases, including inflammatory diseases, metabolic disorders, and cancers. Microbial EVs in feces, blood, and urine show significant differences in their profiles between patients with a particular disease and healthy subjects, demonstrating the potential of microbial EVs as biomarkers for disease diagnosis, especially for assessing disease risk. Furthermore, microbial EV therapy offers a variety of advantages over live biotherapeutics and human cell EV (or exosome) therapy for the treatment of intractable diseases. In summary, microbial EVs are a new tool in medicine, and microbial EV technology might provide us with innovative diagnostic and therapeutic solutions in precision medicine.Keywords
Funding Information
- Ministry of Health and Welfare (HR14C0001, HR16C0001)
- Ministry of Trade, Industry and Energy (20013712)
This publication has 127 references indexed in Scilit:
- Extracellular Vesicles Derived from Gut Microbiota, Especially Akkermansia muciniphila, Protect the Progression of Dextran Sulfate Sodium-Induced ColitisPLOS ONE, 2013
- Exosome mimetics: a novel class of drug delivery systemsInternational Journal of Nanomedicine, 2012
- Proteomic analysis of outer membrane vesicles derived from Pseudomonas aeruginosaProteomics, 2011
- The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept)Genes & Nutrition, 2011
- NOD-Like Receptor Activation by Outer Membrane Vesicles from Vibrio cholerae Non-O1 Non-O139 Strains Is Modulated by the Quorum-Sensing Regulator HapRInfection and Immunity, 2011
- Bacillus anthracis produces membrane-derived vesicles containing biologically active toxinsProceedings of the National Academy of Sciences, 2010
- Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane VesiclesAnnual Review of Microbiology, 2010
- Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammationAllergy, 2010
- Virulence and Immunomodulatory Roles of Bacterial Outer Membrane VesiclesMicrobiology and Molecular Biology Reviews, 2010
- Release of outer membrane vesicles by Gram‐negative bacteria is a novel envelope stress responseMolecular Microbiology, 2006